Gain Therapeutics, Inc.
NASDAQ:GANXBiotechnology
Healthcare
$1.18 +3.09%
+$0.06 today
- Market cap
- $50.33M
- Beta
- 0.16
- P/E (TTM)
- -3.6
- EPS (TTM)
- -$0.50
52W Low $1.41High $4.34
Volume 4.26M
Average 0.64M
Private 5-step workspace
Build a GANX investment thesis
Turn Gain Therapeutics, Inc. research into a structured decision across business quality, moat, management, intrinsic value, and synthesis.
Log in to save your stock analysis
Your answers are private and saved per stock, so you can come back to the thesis later.
Continue the stock analysis
Jump to another research area for this company.